SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (475)12/12/1999 3:47:00 PM
From: tommysdad  Respond to of 3044
 
<<So....... ok, don't ignore them, but..... how does one invest in them and still gain exposure to biotech-like "return potential"?>>

Good question (that's code for: "Gee, I don't know, but I'll think about it"). Rather than go too OT on the MLNM thread, I'll try to address that on the ARQL thread.

<<Most biologists are convinced that we'll need the atom jugglers for awhile longer. It'll be awhile until we turn them into lever pushers.>>

Make the levers colorful enough, and I'll be fine.



To: scaram(o)uche who wrote (475)12/13/1999 9:19:00 AM
From: scaram(o)uche  Respond to of 3044
 
biz.yahoo.com

Monday December 13, 7:59 am Eastern Time

Company Press Release

SOURCE: Millennium Pharmaceuticals, Inc.

Millennium Delivers Ninth Antibacterial Target for
Screening to Wyeth-Ayerst

- Significant Progress in Target Deliveries Prompts Milestone -